Monday, December 24, 2007

Pneumonia Vaccine Is Keeping Kids Healthier

Pneumonia Vaccine Is Keeping Kids Healthier
FRIDAY, Dec. 7 (HealthDay News) -- Among children younger than 2,receiving the pneumococcal vaccine appears to be associated with fewerhospitalizations for pneumonia and reduced health-care expenses, accordingto a new report from the U.S. Centers for Disease Control andPrevention.
Beginning in 2000, the 7-valent pneumococcal conjugate vaccine (PDV7)became part of the routine immunization schedule for American children,according to background information in a news release about the study.
The vaccine -- which protects against pneumococcal pneumonia, causedby the Streptococcus pneumoniae bacteria -- is recommended for allchildren aged 2 months to 23 months and children aged 24 months to 59months who are at increased risk for pneumococcal disease.
Between 2002 and 2005, the number of American children aged 19 monthsto 35 months receiving three or more doses of the PDV7 vaccine increasedfrom 41 percent to 83 percent.
For this study, the CDC researchers analyzed 1997 to 2004 healthrecords from a database of about 40 large U.S. employers. The findings arepublished in the December issue of the Archives of Pediatrics &Adolescent Medicine.
"Comparing the rates in 2004 with those in the baseline period of 1997to 1999 among children younger than two years, hospitalizations due toall-cause pneumonia declined from 11.5 to 5.5 per 1,000 children (52.4percent decline) and ambulatory (outpatient) visits due to all-causepneumonia declined from 99.3 to 58.5 per 1,000 children (41.1 percentdecline)," the study authors wrote.
"Rates of hospitalization due to pneumococcal pneumonia declined from0.6 to 0.3 per 1,000 children (57.6 percent decline) and rates ofambulatory visits declined from 1.7 to 0.9 per 1,000 children (46.9percent decline)," the authors added.
The findings add to growing evidence of the benefits of PCV7vaccination and suggest the vaccine plays an important role in reducingpneumonia rates and health-care costs, the authors concluded.

No comments: